Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 03 April, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 530001 | NSE: GUJALKALI

Gujarat Alkalies & Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 3, 2025, 1:24 am

Market Cap 4,752 Cr.
Current Price 648
High / Low 900/484
Stock P/E
Book Value 842
Dividend Yield0.00 %
ROCE3.83 %
ROE3.88 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Gujarat Alkalies & Chemicals Ltd

Competitors of Gujarat Alkalies & Chemicals Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Caprolactam Chemicals Ltd 18.9 Cr. 41.2 65.0/38.2 11.60.00 %6.86 %3.67 % 10.0
Standard Industries Ltd 124 Cr. 19.8 39.0/17.5134 20.15.31 %6.83 %6.28 % 5.00
Gujarat Alkalies & Chemicals Ltd 4,752 Cr. 648 900/484 8420.00 %3.83 %3.88 % 10.0
GHCL Ltd 6,133 Cr. 639 779/47210.2 3311.88 %20.6 %17.3 % 10.0
Tata Chemicals Ltd 21,685 Cr. 852 1,247/75644.5 8711.76 %7.81 %2.32 % 10.0
Industry Average6,745.20 Cr488.1761.63392.451.52%9.52%6.89%9.17

All Competitor Stocks of Gujarat Alkalies & Chemicals Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 1,0751,1411,1281,1271,1231,1389139719211,0029779911,029
Expenses 709792778969885936882955941998923945951
Operating Profit 3663493511592382023116-204544678
OPM % 34%31%31%14%21%18%3%2%-2%0%6%5%8%
Other Income 376226812715334915
Interest 11238810111112111110
Depreciation 505250607988899596979710098
Profit before tax 317303305118157115-57-18-123-102-50-16-15
Tax % 37%27%37%49%44%38%0%-0%-6%-55%-11%15%-27%
Net Profit 201221191618771-57-18-115-46-45-18-11
EPS in Rs 27.4230.0525.998.2411.879.67-7.78-2.50-15.68-6.29-6.06-2.48-1.53

Last Updated: February 28, 2025, 7:40 pm

Below is a detailed analysis of the quarterly data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹1,029.00 Cr.. The value appears strong and on an upward trend. It has increased from 991.00 Cr. (Sep 2024) to ₹1,029.00 Cr., marking an increase of 38.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹951.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 945.00 Cr. (Sep 2024) to ₹951.00 Cr., marking an increase of 6.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹78.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Sep 2024) to ₹78.00 Cr., marking an increase of 32.00 Cr..
  • For OPM %, as of Dec 2024, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Sep 2024) to 8.00%, marking an increase of 3.00%.
  • For Other Income, as of Dec 2024, the value is ₹15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Sep 2024) to ₹15.00 Cr., marking a decrease of 34.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Sep 2024) to ₹10.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹98.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 100.00 Cr. (Sep 2024) to ₹98.00 Cr., marking a decrease of 2.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹-15.00 Cr.. The value appears strong and on an upward trend. It has increased from -16.00 Cr. (Sep 2024) to ₹-15.00 Cr., marking an increase of 1.00 Cr..
  • For Tax %, as of Dec 2024, the value is -27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Sep 2024) to -27.00%, marking a decrease of 42.00%.
  • For Net Profit, as of Dec 2024, the value is ₹-11.00 Cr.. The value appears strong and on an upward trend. It has increased from -18.00 Cr. (Sep 2024) to ₹-11.00 Cr., marking an increase of 7.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is -1.53. The value appears strong and on an upward trend. It has increased from -2.48 (Sep 2024) to -1.53, marking an increase of 0.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:08 pm

MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 1,9952,0702,4553,1612,7252,4293,7594,5163,8073,999
Expenses 1,6601,6221,6692,0462,1482,0722,7743,5683,7753,817
Operating Profit 3354487861,11557735798494932182
OPM % 17%22%32%35%21%15%26%21%1%5%
Other Income 455610662906746429070
Interest 1013152114156194544
Depreciation 107111127140162174198276377392
Profit before tax 2623817491,016491235826695-300-184
Tax % 16%19%29%32%32%29%32%41%-21%
Net Profit 220307534690332166560410-237-120
EPS in Rs 29.9041.8572.7893.9845.2222.5776.2255.78-32.25-16.36
Dividend Payout % 15%12%9%9%18%35%13%42%-43%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)39.55%73.94%29.21%-51.88%-50.00%237.35%-26.79%-157.80%
Change in YoY Net Profit Growth (%)0.00%34.40%-44.73%-81.10%1.88%287.35%-264.14%-131.02%

Gujarat Alkalies & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:4%
3 Years:16%
TTM:1%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:0%
Stock Price CAGR
10 Years:15%
5 Years:21%
3 Years:-11%
1 Year:-11%
Return on Equity
10 Years:%
5 Years:5%
3 Years:4%
Last Year:-4%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 11:38 pm

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 73737373737373737373
Reserves 2,8543,2823,7484,2224,5225,3015,8266,0666,0026,112
Borrowings 295353291247205498594597544603
Other Liabilities 6717268599881,0901,2821,4841,5991,4041,625
Total Liabilities 3,8944,4354,9705,5315,8917,1547,9778,3358,0238,413
Fixed Assets 1,8212,0732,1042,3002,6102,5872,7024,2504,6174,491
CWIP 831512523074451,1091,78754495157
Investments 8541,0161,1451,0651,2422,0922,1101,8312,0932,377
Other Assets 1,1361,1961,4691,8581,5941,3661,3791,7101,2181,388
Total Assets 3,8944,4354,9705,5315,8917,1547,9778,3358,0238,413

Below is a detailed analysis of the balance sheet data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 73.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹6,112.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,002.00 Cr. (Mar 2024) to ₹6,112.00 Cr., marking an increase of 110.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹603.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 544.00 Cr. (Mar 2024) to ₹603.00 Cr., marking an increase of 59.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹1,625.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,404.00 Cr. (Mar 2024) to ₹1,625.00 Cr., marking an increase of 221.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹8,413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,023.00 Cr. (Mar 2024) to ₹8,413.00 Cr., marking an increase of 390.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹4,491.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,617.00 Cr. (Mar 2024) to ₹4,491.00 Cr., marking a decrease of 126.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹157.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2024) to ₹157.00 Cr., marking an increase of 62.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹2,377.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,093.00 Cr. (Mar 2024) to ₹2,377.00 Cr., marking an increase of 284.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹1,388.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,218.00 Cr. (Mar 2024) to ₹1,388.00 Cr., marking an increase of 170.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹8,413.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,023.00 Cr. (Mar 2024) to ₹8,413.00 Cr., marking an increase of 390.00 Cr..

Notably, the Reserves (₹6,112.00 Cr.) exceed the Borrowings (603.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +20150251483863042173596067
Cash from Investing Activity +-352-467-395-581-634-334-804-662-90
Cash from Financing Activity +8413-116-136-14622612-140-277
Net Cash Flow-67493122-150313-58158-301

Free Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow40.0095.00495.00-246.00372.00-141.00390.00352.00-512.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days605860565043292317
Inventory Days999414799928810111193
Days Payable9912515413412611110111986
Cash Conversion Cycle602753221721291525
Working Capital Days908399961072081618
ROCE %11%18%24%11%5%13%11%-4%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters46.28%46.28%46.28%46.28%46.28%46.28%46.28%46.28%46.28%46.28%46.28%46.28%
FIIs1.82%2.05%1.98%2.07%2.07%1.98%1.88%2.07%2.10%1.92%1.94%1.79%
DIIs1.68%1.63%1.47%1.45%1.51%1.51%1.96%2.17%3.13%3.46%3.76%4.14%
Public50.22%50.04%50.27%50.19%50.13%50.22%49.88%49.49%48.48%48.34%48.01%47.79%
No. of Shareholders77,77387,42887,08385,35484,09785,39388,02086,69882,71979,56078,68175,697

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Regular Savings Fund75,0470.185.9675,0472025-04-020%
Motilal Oswal Nifty Microcap 250 Index Fund31,2630.182.4875,0472025-04-02-58.34%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -32.2555.7876.2222.5745.22
Diluted EPS (Rs.) -32.2555.7876.2222.5745.22
Cash EPS (Rs.) 33.38115.99103.4646.4667.36
Book Value[Excl.RevalReserv]/Share (Rs.) 827.30835.97803.30731.86625.79
Book Value[Incl.RevalReserv]/Share (Rs.) 827.30835.97803.30731.86625.79
Revenue From Operations / Share (Rs.) 518.34615.01511.82330.82371.00
PBDIT / Share (Rs.) 30.79157.51140.6057.9690.89
PBIT / Share (Rs.) -20.60119.92113.6734.2168.86
PBT / Share (Rs.) -26.67117.27112.8332.1166.94
Net Profit / Share (Rs.) -18.0178.3976.5222.7245.32
NP After MI And SOA / Share (Rs.) -32.2555.7876.2222.5745.22
PBDIT Margin (%) 5.9325.6127.4717.5124.49
PBIT Margin (%) -3.9719.4922.2010.3418.55
PBT Margin (%) -5.1419.0622.049.7018.04
Net Profit Margin (%) -3.4712.7414.956.8612.21
NP After MI And SOA Margin (%) -6.229.0614.896.8212.18
Return on Networth / Equity (%) -3.896.679.483.087.22
Return on Capital Employeed (%) -2.0711.7511.523.849.42
Return On Assets (%) -2.954.917.012.315.63
Long Term Debt / Equity (X) 0.050.070.090.080.02
Total Debt / Equity (X) 0.080.090.100.080.03
Asset Turnover Ratio (%) 0.460.550.490.370.47
Current Ratio (X) 1.231.681.491.782.60
Quick Ratio (X) 0.671.131.011.412.15
Inventory Turnover Ratio (X) 6.756.456.976.166.40
Dividend Payout Ratio (NP) (%) -73.0217.9210.4935.4417.69
Dividend Payout Ratio (CP) (%) 123.0310.707.7517.2711.89
Earning Retention Ratio (%) 173.0282.0889.5164.5682.31
Cash Earning Retention Ratio (%) -23.0389.3092.2582.7388.11
Interest Coverage Ratio (X) 5.0759.43168.0027.5347.54
Interest Coverage Ratio (Post Tax) (X) -1.9730.5892.4311.7924.71
Enterprise Value (Cr.) 5324.434435.116873.062607.271735.82
EV / Net Operating Revenue (X) 1.400.981.831.070.63
EV / EBITDA (X) 23.553.836.666.132.60
MarketCap / Net Operating Revenue (X) 1.300.951.751.040.60
Retention Ratios (%) 173.0282.0789.5064.5582.30
Price / BV (X) 0.810.701.120.470.35
Price / Net Operating Revenue (X) 1.300.951.751.040.60
EarningsYield -0.040.090.080.060.20

After reviewing the key financial ratios for Gujarat Alkalies & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 5. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
  • For Diluted EPS (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 5. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
  • For Cash EPS (Rs.), as of Mar 24, the value is 33.38. This value is within the healthy range. It has decreased from 115.99 (Mar 23) to 33.38, marking a decrease of 82.61.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 827.30. It has decreased from 835.97 (Mar 23) to 827.30, marking a decrease of 8.67.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 827.30. It has decreased from 835.97 (Mar 23) to 827.30, marking a decrease of 8.67.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 518.34. It has decreased from 615.01 (Mar 23) to 518.34, marking a decrease of 96.67.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 30.79. This value is within the healthy range. It has decreased from 157.51 (Mar 23) to 30.79, marking a decrease of 126.72.
  • For PBIT / Share (Rs.), as of Mar 24, the value is -20.60. This value is below the healthy minimum of 0. It has decreased from 119.92 (Mar 23) to -20.60, marking a decrease of 140.52.
  • For PBT / Share (Rs.), as of Mar 24, the value is -26.67. This value is below the healthy minimum of 0. It has decreased from 117.27 (Mar 23) to -26.67, marking a decrease of 143.94.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is -18.01. This value is below the healthy minimum of 2. It has decreased from 78.39 (Mar 23) to -18.01, marking a decrease of 96.40.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 2. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
  • For PBDIT Margin (%), as of Mar 24, the value is 5.93. This value is below the healthy minimum of 10. It has decreased from 25.61 (Mar 23) to 5.93, marking a decrease of 19.68.
  • For PBIT Margin (%), as of Mar 24, the value is -3.97. This value is below the healthy minimum of 10. It has decreased from 19.49 (Mar 23) to -3.97, marking a decrease of 23.46.
  • For PBT Margin (%), as of Mar 24, the value is -5.14. This value is below the healthy minimum of 10. It has decreased from 19.06 (Mar 23) to -5.14, marking a decrease of 24.20.
  • For Net Profit Margin (%), as of Mar 24, the value is -3.47. This value is below the healthy minimum of 5. It has decreased from 12.74 (Mar 23) to -3.47, marking a decrease of 16.21.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is -6.22. This value is below the healthy minimum of 8. It has decreased from 9.06 (Mar 23) to -6.22, marking a decrease of 15.28.
  • For Return on Networth / Equity (%), as of Mar 24, the value is -3.89. This value is below the healthy minimum of 15. It has decreased from 6.67 (Mar 23) to -3.89, marking a decrease of 10.56.
  • For Return on Capital Employeed (%), as of Mar 24, the value is -2.07. This value is below the healthy minimum of 10. It has decreased from 11.75 (Mar 23) to -2.07, marking a decrease of 13.82.
  • For Return On Assets (%), as of Mar 24, the value is -2.95. This value is below the healthy minimum of 5. It has decreased from 4.91 (Mar 23) to -2.95, marking a decrease of 7.86.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 23) to 0.05, marking a decrease of 0.02.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.46. It has decreased from 0.55 (Mar 23) to 0.46, marking a decrease of 0.09.
  • For Current Ratio (X), as of Mar 24, the value is 1.23. This value is below the healthy minimum of 1.5. It has decreased from 1.68 (Mar 23) to 1.23, marking a decrease of 0.45.
  • For Quick Ratio (X), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 1.13 (Mar 23) to 0.67, marking a decrease of 0.46.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.75. This value is within the healthy range. It has increased from 6.45 (Mar 23) to 6.75, marking an increase of 0.30.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is -73.02. This value is below the healthy minimum of 20. It has decreased from 17.92 (Mar 23) to -73.02, marking a decrease of 90.94.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 123.03. This value exceeds the healthy maximum of 50. It has increased from 10.70 (Mar 23) to 123.03, marking an increase of 112.33.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 173.02. This value exceeds the healthy maximum of 70. It has increased from 82.08 (Mar 23) to 173.02, marking an increase of 90.94.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is -23.03. This value is below the healthy minimum of 40. It has decreased from 89.30 (Mar 23) to -23.03, marking a decrease of 112.33.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 5.07. This value is within the healthy range. It has decreased from 59.43 (Mar 23) to 5.07, marking a decrease of 54.36.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -1.97. This value is below the healthy minimum of 3. It has decreased from 30.58 (Mar 23) to -1.97, marking a decrease of 32.55.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 5,324.43. It has increased from 4,435.11 (Mar 23) to 5,324.43, marking an increase of 889.32.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.40. This value is within the healthy range. It has increased from 0.98 (Mar 23) to 1.40, marking an increase of 0.42.
  • For EV / EBITDA (X), as of Mar 24, the value is 23.55. This value exceeds the healthy maximum of 15. It has increased from 3.83 (Mar 23) to 23.55, marking an increase of 19.72.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.30, marking an increase of 0.35.
  • For Retention Ratios (%), as of Mar 24, the value is 173.02. This value exceeds the healthy maximum of 70. It has increased from 82.07 (Mar 23) to 173.02, marking an increase of 90.95.
  • For Price / BV (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has increased from 0.70 (Mar 23) to 0.81, marking an increase of 0.11.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.30, marking an increase of 0.35.
  • For EarningsYield, as of Mar 24, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 23) to -0.04, marking a decrease of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Gujarat Alkalies & Chemicals Ltd as of April 3, 2025 is: 399.88

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 3, 2025, Gujarat Alkalies & Chemicals Ltd is Overvalued by 38.29% compared to the current share price 648.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Gujarat Alkalies & Chemicals Ltd as of April 3, 2025 is: 191.28

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 3, 2025, Gujarat Alkalies & Chemicals Ltd is Overvalued by 70.48% compared to the current share price 648.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -52.17%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (4,793.50 cr) compared to borrowings (422.70 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (2.50 cr) and profit (315.60 cr) over the years.
  1. The stock has a low average ROCE of 9.89%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 59.67, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 29.89, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Alkalies & Chemicals Ltd:
    1. Net Profit Margin: -3.47%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: -2.07% (Industry Average ROCE: 9.52%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: -3.89% (Industry Average ROE: 6.89%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): -1.97
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.67
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 0 (Industry average Stock P/E: 61.63)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.08
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Gujarat Alkalies & Chemicals Ltd. is a Public Limited Listed company incorporated on 29/03/1973 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24110GJ1973PLC002247 and registration number is 002247. Currently Company is involved in the business activities of Manufacture of basic chemicals, fertilizer and nitrogen compounds, plastics and synthetic rubber in primary forms. Company's Total Operating Revenue is Rs. 3806.63 Cr. and Equity Capital is Rs. 73.44 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Chemicals - Inorganic - Caustic Soda/Soda AshP.O.: Ranoli Vadodra District Gujarat 391350investor_relations@gacl.co.in
http://www.gacl.com
Management
NamePosition Held
Dr. Hasmukh AdhiaChairman
Mr. P SwaroopManaging Director
Mr. Rajiv Lochan JainIndependent Director
Mr. Nitin ShuklaIndependent Director
Mr. Shridevi ShuklaIndependent Director
Dr. Rahul GuptaDirector
Mr. Bimal JulkaIndependent Director
Dr. Chinmay GhoroiIndependent Director

FAQ

What is the intrinsic value of Gujarat Alkalies & Chemicals Ltd?

Gujarat Alkalies & Chemicals Ltd's intrinsic value (as of 02 April 2025) is ₹399.88 — 38.29% lower the current market price of ₹648.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,752 Cr. market cap, FY2025-2026 high/low of ₹900/484, reserves of 6,112 Cr, and liabilities of 8,413 Cr.

What is the Market Cap of Gujarat Alkalies & Chemicals Ltd?

The Market Cap of Gujarat Alkalies & Chemicals Ltd is 4,752 Cr..

What is the current Stock Price of Gujarat Alkalies & Chemicals Ltd as on 02 April 2025?

The current stock price of Gujarat Alkalies & Chemicals Ltd as on 02 April 2025 is 648.

What is the High / Low of Gujarat Alkalies & Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Gujarat Alkalies & Chemicals Ltd stocks is ₹900/484.

What is the Stock P/E of Gujarat Alkalies & Chemicals Ltd?

The Stock P/E of Gujarat Alkalies & Chemicals Ltd is .

What is the Book Value of Gujarat Alkalies & Chemicals Ltd?

The Book Value of Gujarat Alkalies & Chemicals Ltd is 842.

What is the Dividend Yield of Gujarat Alkalies & Chemicals Ltd?

The Dividend Yield of Gujarat Alkalies & Chemicals Ltd is 0.00 %.

What is the ROCE of Gujarat Alkalies & Chemicals Ltd?

The ROCE of Gujarat Alkalies & Chemicals Ltd is 3.83 %.

What is the ROE of Gujarat Alkalies & Chemicals Ltd?

The ROE of Gujarat Alkalies & Chemicals Ltd is 3.88 %.

What is the Face Value of Gujarat Alkalies & Chemicals Ltd?

The Face Value of Gujarat Alkalies & Chemicals Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Gujarat Alkalies & Chemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE